In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘summary of the operation’ below, containing the information provided by the parties.<\/p>\n
This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.<\/p>\n
The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.<\/p>\n
Names of the companies and groups concerned:<\/strong><\/p>\n Nature of the operation<\/strong><\/p>\n Economic sectors concerned<\/strong><\/p>\n Deadline for interested third parties to submit their observations<\/strong><\/p>\n NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n The Competition Council received notification of an economic concentration project operation concerning the exclusive takeover by the company ‘Sothema SA’ of the company ‘Soludia Maghreb SA’ through the acquisition of all its capital and related voting rights.<\/p>\n ‘Sothema SA’ is a Moroccan joint-stock company, with its registered office at Quartier Industriel Bouskoura – Bouskoura 27182, registered with the Casablanca Trade Register under number 35631. The company specializes in the manufacture and marketing of pharmaceuticals.<\/p>\n ‘Soludia Maghreb SA’ is a Moroccan joint-stock company, registered with the T\u00e9mara Trade Register under number 144277 and with its registered office at Zone industrielle n\u00b019 Sidi Yahya Zaers Tamesna, T\u00e9mara, Morocco. It specializes in the manufacture of concentrates for hemodialysis and more generally, in the manufacture, import, export, wholesale, and distribution of pharmaceutical products, medical devices, and dietary supplements.<\/p>\n <\/p>\n Done in Rabat on September 01, 2025<\/p>\n","protected":false},"excerpt":{"rendered":" In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘summary of the operation’ below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies and groups concerned: The acquirer: ‘Sothema SA’; The target: ‘Soludia Maghreb SA’. Nature of the operation Exclusive takeover. Economic sectors concerned The market for the import and manufacture of hemodialysis concentrates (HD); The market for the import of Peritoneal Dialysis Solutions (DP); The market for the import of solutions for hemofiltration. Deadline for interested third parties to submit their observations 10 days from the date of publication of this press release, i.e. September 11, 2025. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council received notification of an economic concentration project operation concerning the exclusive takeover by the company ‘Sothema SA’ of the company ‘Soludia Maghreb SA’ through the acquisition of all its capital and related voting rights. ‘Sothema SA’ is a Moroccan joint-stock company, with its registered office at Quartier Industriel Bouskoura – Bouskoura 27182, registered with the Casablanca Trade Register under number 35631. The company specializes in the manufacture and marketing of pharmaceuticals. ‘Soludia Maghreb SA’ is a Moroccan joint-stock company, registered with the T\u00e9mara Trade Register under number 144277 and with its registered office at Zone industrielle n\u00b019 Sidi Yahya Zaers Tamesna, T\u00e9mara, Morocco. It specializes in the manufacture of concentrates for hemodialysis and more generally, in the manufacture, import, export, wholesale, and distribution of pharmaceutical products, medical devices, and dietary supplements. Done in Rabat on September 01, 2025<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-39189","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"\n\n
\n
\n
\n